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A report of the meeting ‘Gene Expression and Signaling in
the Immune System’, Cold Spring Harbor, USA, 22-26 April
2008.
Major themes at this year’s Cold Spring Harbor meeting on
gene expression and signaling in the immune system
included transcriptional control of leukocyte development
and differentiation, antigen receptor gene assembly and
modification, signal transduction by antigen receptors in
control of lymphocyte biology, signal transduction in regula-
tion of inflammatory gene expression and the analysis of
chromatin structure and other epigenetic mechanisms in
control of gene expression.
M Me et ta ab bo ol li ic c   r re eg gu ul la at ti io on n   i in n   l ly ym mp ph ho oc cy yt te e   a ac ct ti iv va at ti io on n
The link between metabolism and regulation of lymphocyte
activity was addressed by Doreen Cantrell (University of
Dundee, UK), who presented data regarding the role of
phosphatidylinositol-3-OH kinase (PI3K) signaling in
regulating T-cell biology. She has used an in vitro model of
murine CD8 T-cell differentiation in which the strength of
PI3K signaling is varied, by culture with either of the
cytokines interleukin (IL)-2 or IL-15, or with
pharmacological inhibitors of the PI3K pathway. She
showed that high levels of PI3K signaling (as in the IL-2
cultures) produced large cells with an effector phenotype,
while low levels (as with IL-15) resulted in small, memory-
like cells. This reflected regulation of two major functional
programs: metabolism, through control of protein
synthesis, and trafficking, through regulated expression of
the chemokine receptor CCR7 and the selectin molecule
CD62L. Cantrell suggested that this enables the PI3K
pathway to match cellular metabolic demands with
migration in vivo, such that high levels of PI3K signaling
would support energy-demanding effector T-cell functions
in the periphery, whereas low levels would direct T cells back
to the nutrient-rich environment of the lymph node.
The intracellular signaling protein Slp2 is also involved in
regulating energy metabolism in lymphocytes. Joaquin
Madrenas (University of Western Ontario, London, Ontario)
suggested that induction of Slp2 in activated mouse T cells and
B cells is necessary to meet the increased metabolic demands
associated with the transition from the quiescent, G0-arrested
state to actively proliferating and differentiating lymphocytes.
He showed that induction of Slp2 led to an increase in the
amount of mitochondrial membrane and the number of
mitochondria, and consistent with this, an increase in ATP
stores. Conversely, Slp2 downregulation inhibited T-cell
activation, as assessed by IL-2 production. Ectopic expression
of Slp2 also protected T cells from apoptosis triggered by the
cell-autonomous, mitochondria-dependent pathway. There-
fore, while its exact role in mitochondrial regulation is not
clear, Slp2 may be critical for diverse aspects of lymphocyte
activation, including energy metabolism and survival.
S Si ig gn na al l   t tr ra an ns sd du uc ct ti io on n   i in n   p pr ro o- -i in nf fl la am mm ma at to or ry y   g ge en ne e
e ex xp pr re es ss si io on n
The NF-κB family of transcription factors critically regulates
pro-inflammatory gene expression in response to a range of
stimuli. Alexander Hoffmann (University of California, San
Diego, USA) reported that one member, NF-κB2/p100, can
function as a novel noncanonical inhibitor in the IκB family,
by mediating retention in the cytoplasm of the NF-κB hetero-
dimer RelA/p50. In contrast to inflammatory signaling,
which activates RelA/50 by degrading canonical IκBs (α, β,
and ε), p100-bound heterodimers are liberated by develop-
mental stimuli such as stimulation via the lymphotoxin-β
receptor (LTβR). Because canonical and noncanonical IκBs
also differ in their stimulus-dependent resynthesis and half-
lives, IκB homeostasis changes depending on the cellular
stimulus. Hoffmann suggested that integration of NF-κB
activation by inflammatory signals and developmental signals
such as LTβR is essential for specifying physiologically
relevant transcriptional programs; dysregulation of this
system, for instance by perturbed IκB homeostasis, may
contribute to cancer or chronic inflammation.In this context, Sankar Ghosh (Yale University School of
Medicine, New Haven, USA) demonstrated a novel function
for a familiar friend, IκBβ. Surprisingly, mice lacking this
NF-κB inhibitor were more resistant to septic shock, and
consistent with this, produced less tumor necrosis factor α
(TNFα). This suggests a role for IκBβ in potentiating
inflammatory gene expression in some contexts. Indeed,
newly synthesized IκBβ (unlike the constitutive pool that
inhibits NF-κB activity) seems to function as a NF-κB
coactivator at the TNFα promoter.
T Tr ra an ns sc cr ri ip pt ti io on na al l   c co on nt tr ro ol l   o of f   l le eu uk ko oc cy yt te e   d de ev ve el lo op pm me en nt t   a an nd d
d di if ff fe er re en nt ti ia at ti io on n
The transcription factor Foxp3 has a critical role in
specifying the gene expression program of regulatory T cells
(Treg). Alexander Rudensky (University of Washington,
Seattle, USA) reported that a sub-module of this Foxp3-
dependent program is co-regulated by IRF4, a transcription
factor necessary for differentiation of the Th2 subclass of
effector T cells. While specific deletion of IRF4 in Treg did not
alter their suppressor activity in vitro, these cells had lower
levels of expression than many of the genes associated with
Th2 differentiation or function (for example, ICOS, cmaf),
and mice lacking IRF4 in Treg succumbed to a Th2-skewed
lymphoproliferative disease. Because IRF4 is a direct target
of Foxp3 and is directly associated with Foxp3, Rudensky
suggested that Foxp3 co-opts IRF4 for regulation of a Th2-
specific submodule of the Treg transcriptional program.
Two talks addressed early events in lineage commitment in
hematopoiesis. Using a multi-lineage progenitor assay,
Hiroshi Kawamoto (RIKEN Research Center for Allergy and
Immunology, Yokohama, Japan) showed that during thymic
differentiation murine T-cell precursors lose B-cell potential
before myeloid potential. Furthermore, he estimated that
30% of thymic macrophages are derived from T-cell
progenitors in vivo. These data fit a model wherein T and B
lymphocytes are derived from common myelo-lymphoid
progenitors (CMLPs), as opposed to common lymphoid
progenitors (CLPs). In ending his talk, Kawamoto presented
the provocative idea that B and T lineages had diverged
before the evolutionary emergence of adaptive immunity.
Although this caused a stir in the audience, Harinder Singh
(University of Chicago, USA) hinted that he might have an
explanation of Kawamoto’s findings. Singh presented data
on the role of the transcription factor Ikaros in B-cell fate
determination in mice. He showed that Ikaros has dual
functions, promoting B-cell development by restraining the
expression of pro-myeloid factors (such as Gfi1), and acting
directly to induce the recombinase (Rag) genes and thereby
recombination at the immunoglobulin heavy-chain locus.
Interestingly, Ikaros was found to bind at pericentromeric
satellite DNA and could therefore play a role in the silencing
of genes encoding key developmental regulators such as
Gfi1, PU.1 and Egr1. Singh presented the intriguing concept
that Ikaros may have played a primordial role in repressing
the Rag genes. Later on, an Ikaros variant evolved that could
refine activation of the Rag genes, thereby allowing for the
development of modern B and T cells.
G Gl lo ob ba al l   a an na al ly ys si is s   o of f   c ch hr ro om ma at ti in n   s st tr ru uc ct tu ur re e
Covalent modifications to histones are essential for
dynamic regulation of gene expression. A plethora of
studies in the past few years, and several talks at this
meeting, mapped histone modifications genome-wide. Keji
Zhao (National Heart, Lung, and Blood Institute, NIH,
Bethesda, USA) used chromatin immunoprecipitation
followed by DNA sequencing (ChIP-seq) to interrogate 38
histone modifications at the promoters of all genes in
human resting T cells. This analysis identified 4,300
different patterns, of which 3,100 were unique (that is,
found only at one gene). In contrast, some patterns were
found at multiple genes; more than 3,000 genes, for
instance, were marked by a ‘modification backbone’
consisting of 17 modifications. By assaying single
nucleosomes, Zhao determined that 14 of these 17
modifications co-localize to the same nucleosome. To
address histone modifications at enhancers, he assayed
41,000 DNase hypersensitive sites (which are putative
enhancers), and discovered 13,000 distinct patterns, of
which 1,100 were unique. Zhao’s study underscored the
diversity of histone modification patterns at gene
regulatory elements, but also showed that a limited
number of such patterns exist.
Matthias Merkenschlager (Imperial College School of
Medicine, London, UK) presented provocative work descri-
bing a noncanonical function of cohesin in gene regulation
(independent of its function in chromosome segregation),
which seems to require the insulator-binding protein CTCF.
These results suggest a model whereby, in mammalian cells,
CTCF recruits cohesin. Chromatin immunoprecipitation
followed by DNA microarray analysis (ChIP-chip) showed
that CTCF and cohesin co-localize to a subset of conserved
noncoding sequences. These results suggest a model where-
by CTCF recruits cohesin to these sites to mediate an
insulating function (and perhaps other activities). Interest-
ingly, Merkenschlager noted that because cohesin does not
co-localize with CTCF in Drosophila, this mechanism of
gene regulation by cohesin is vertebrate specific.
E Ep pi ig ge en ne et ti ic c   r re eg gu ul la at ti io on n   o of f   i in nf fl la am mm ma at to or ry y   g ge en ne e   e ex xp pr re es ss si io on n
Two talks addressed the role of epigenetic mechanisms in
regulation of inflammatory gene expression. In particular,
they addressed the induction of primary response genes
(direct transcriptional targets) and secondary response
genes (indirect transcriptional targets that require de novo
protein synthesis for their induction) following Toll-like
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Angeles, USA) showed in mouse cells that secondary
response genes require signal-dependent chromatin re-
modeling by the BAF complex for their induction; in
contrast, the promoters of many primary response genes are
marked by CpG islands, which have low histone density and
do not assemble into stable nucleosomes, and these pro-
moters are induced independently of chromatin remodeling.
Ruslan Medzhitov (Yale University School of Medicine, New
Haven, USA) extended this analysis of mouse macrophages
to show that in their basal state, promoters of primary
response genes are marked by trimethylation on lysine 4 of
histone H3 (H3K4), acetylation on lysine 9 of H3 (H3K9),
and engaged RNA polymerase II, whereas promoters of
secondary response genes acquired these features in a
signal-dependent manner. Medzhitov proposed a model
whereby arrest of transcription elongation at primary
response genes is derepressed by inducible recruitment of
pTEFβ, the essential elongation factor, via a ‘histone code’
for transcription elongation.
A An nt ti ig ge en n   r re ec ce ep pt to or r   g ge en ne e   a as ss se em mb bl ly y   a an nd d   d di iv ve er rs si if fi ic ca at ti io on n
In regard to mechanisms that target the VDJ recombinase to
the antigen receptor loci, Marjorie Oettinger (Harvard
Medical School, Boston, USA) showed that the PHD domain
of the recombinase subunit Rag2 binds to histone peptides
that are trimethylated at H3K4 and symmetrically dimethy-
lated at H3 arginine 2, in both mouse and human systems.
While dispensable for in vitro VDJ recombination, the PHD
finger was essential in vivo for recruiting Rag2 to its target
genes. Moreover, recombination was reduced by PHD
mutations that abolish histone binding, or by altering global
levels of H3K4 trimethylation. These results suggest an
essential role for the PHD finger in targeting Rag2 to antigen
receptor genes and, therefore, in VDJ recombination.
David Schatz (Yale University School of Medicine, New
Haven, USA) also addressed the issue of in vivo targeting of
the Rag1 and Rag2 proteins. He used an elegant system of
mouse strains that harbor catalytically inactive Rag1
mutants, so that Rag1 and Rag2 binding could be captured in
the absence of ongoing VDJ recombination. Schatz
established that the Rag proteins are recruited to ‘recombi-
nation centers’ - small, focused regions in the antigen
receptor loci - to initiate VDJ recombination. Moreover, the
two Rag proteins can be recruited independently to these
loci; for Rag1, recruitment may be mediated by
recombination signal sequences with ‘open’, accessible
chromatin, whereas Rag2 binding mirrored H3K4 trimethy-
lation patterns, consistent with the results of Oettinger.
The role of the enzyme activation-induced cytidine de-
aminase (AID) in antibody diversification was discussed by
Michael Neuberger (MRC Laboratory of Molecular Biology,
Cambridge, UK). Somatic hypermutation and class switch
recombination are initiated by AID-mediated deoxycytidine
deamination, resulting in a U:G mismatch and uracil
excision or mismatch recognition and repair. Whereas AID
targeting to a rearranged immunoglobulin gene variable
region results in somatic hypermutation, AID mediates class
switching at S regions in the immunoglobulin gene constant
region. In an effort to understand the molecular basis of this
differential activity, Neuberger used a yeast two-hybrid
screen and identified CTNNBL1 (beta catenin-like protein 1)
as an AID-interacting protein. Interestingly, he found that
an AID mutant deficient in CTNNBL1 binding retains
deamination activity but is impaired in class switching,
suggesting that CTNNBL1 may specifically regulate AID-
dependent class switching.
C Ce el ll l- -f fa at te e   d de et te er rm mi in na at ti io on n   i in n   t th he e   i im mm mu un ne e   s sy ys st te em m
A few talks focused on the role of asymmetric division in
cell-fate determination, and provided compelling evidence
suggesting that the cell fate determinant Numb is critical in
determining lineage commitment in the immune system.
Tannishtha Reya (Duke University Medical Center, Durham,
USA) used a reporter system that marks Notch expression to
study stem-cell commitment, and showed that all of the
following are potential outcomes of stem cell division:
symmetric renewal; symmetric commitment; and asym-
metric division. Interestingly, she found that the relative
ratios of the outcomes could be regulated in a context-
dependent manner. For instance, she found a normal
balance between asymmetric and symmetric division in
chronic myeloid leukemia, but increased symmetric renewal
in acute myeloid leukemia (AML). Importantly, enforced
expression of the Notch signaling antagonist Numb
corrected the imbalance in AML, providing a basis for
potential future therapies.
Steve Reiner (University of Pennsylvania, Philadelphia,
USA) and Sarah Russell (University of Melbourne, Australia)
also described asymmetric cell division, but in the context of
an immune response. Reiner showed that following antigen
triggering, T cells become polarized with respect to the
immunological synapse they make with the antigen-
presenting cell. Cell-fate determinants, such as Numb and
the transcription factor T-bet, become localized to the
immunological synapse (proximal) side of the cell, whereas
protein kinase C-ζ becomes partitioned to the distal side of
the cell. Following the first division, factors asymmetrically
segregate into the daughter cells, such that the proximal
daughter gives rise to effector cells and the distal daughter
develops into memory cells. Reiner further speculated that
T-bet is responsible for commitment to an effector lineage,
whereas the transcirption factor EOMES promotes memory
cells. Similarly, Russell showed that the polarity
determinants Par complex and Scribble complex antagonize
each other to polarize T cells during an immune response.
She showed that, whereas cell-surface proteins such as CD8
http://genomebiology.com/2008/9/7/315 Genome B Bi io ol lo og gy y 2008, Volume 9, Issue 7, Article 315 Horng et al. 315.3
Genome B Bi io ol lo og gy y   2008, 9 9: :315and LFA1 are not polarized during cell division, Scribble
remains proximal and Numb remains distal throughout, thus
providing a basis for formation of asymmetric daughter cells.
The immune system has been a rich model for addressing
how signal transduction and gene regulation control diverse
and fundamental biological processes. This was underscored
at the 2008 meeting. We look forward to the next meeting in
2010, and anticipate follow-up to the work reported here as
well as new stories on signaling and transcription in the
immune system.
http://genomebiology.com/2008/9/7/315 Genome B Bi io ol lo og gy y 2008, Volume 9, Issue 7, Article 315 Horng et al. 315.4
Genome B Bi io ol lo og gy y   2008, 9 9: :315